<H1>Chapter DOI: 10.1208/aapsj070357<br/>Cited-By Count: 13</H1><table border="1" width="30%"><tr><td>Total References</td><td>32</td></tr><tr><td>Springer references</td><td>0</td></tr><tr><td>Non Springer references</td><td>32</td></tr><tr><td>BibStructured Count</td><td width="10%">30</td></tr><tr><td>BibUnstructured Count</td><td width="10%">2</td></tr><tr><td>DOI already available in SpringerLink</td><td>18</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>5</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>0</td></tr><tr><td>DOI Obtained For Non Springer</td><td>5</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>5</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>0</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibArticle</td><td>Goonetilleke NP, McShane H, Hannan CM, Anderson RJ, Brookes RH, Hill AV. Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modofied vaccinia virus Ankara.<Emphasis Type="Italic">J Immunol</Emphasis>. 2003;171:1602&#8211;1609.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR2</td><td>BibArticle</td><td>Kaul D, Ogra PL. Mucosal resonses to parenteral and mucosal vaccines.<Emphasis Type="Italic">Dev Biol Stand.</Emphasis> 1998;95:141&#8211;146.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR3</td><td>BibArticle</td><td>Liu XS, Abdul-Jabbar I, Qi YM, Frazer IH, Zhou J. Mucosal immunisation with papillomavirus virus-like particles elicits systemic and mucosal immunity in mice.<Emphasis Type="Italic">Virology</Emphasis>. 1998;252:39&#8211;45.</td><td><a href=http://dx.doi.org/10.1006/viro.1998.9442>10.1006/viro.1998.9442</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR4</td><td>BibArticle</td><td>McCluskie MJ, Weeratna RD, Payette PJ, Davis HL. Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNA.<Emphasis Type="Italic">FEMS Immunol Med Microbiol</Emphasis>. 2002;32:179&#8211;185.</td><td><a href=http://dx.doi.org/10.1111/j.1574-695X.2002.tb00551.x>10.1111/j.1574-695X.2002.tb00551.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR5</td><td>BibArticle</td><td>McGhee JR, Mestecky J, Dertzbaugh MT, Eldridge JH, Hirasawa M, Kiyono H. The mucosal immune system: from fundamental concepts to vaccine development.<Emphasis Type="Italic">Vaccine</Emphasis>. 1992;10:75&#8211;88.</td><td><a href=http://dx.doi.org/10.1016/0264-410X(92)90021-B>10.1016/0264-410X(92)90021-B</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR6</td><td>BibArticle</td><td>Liljeqvist S, Stahl S. Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines.<Emphasis Type="Italic">J Biotechnol</Emphasis>. 1999;73:1&#8211;33.</td><td><a href=http://dx.doi.org/10.1016/S0168-1656(99)00107-8>10.1016/S0168-1656(99)00107-8</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR7</td><td>BibArticle</td><td>Rappuoli R, Pizza M, Douce G, Dougan G. Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins.<Emphasis Type="Italic">Immunol Today</Emphasis>. 1999;20:493&#8211;500.</td><td><a href=http://dx.doi.org/10.1016/S0167-5699(99)01523-6>10.1016/S0167-5699(99)01523-6</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR8</td><td>BibArticle</td><td>Takahashi I, Marinaro M, Kiyono H, et al. Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin.<Emphasis Type="Italic">J Infect Dis</Emphasis>. 1996;173:627&#8211;635.</td><td><a href=http://dx.doi.org/10.1093/infdis/173.3.627>10.1093/infdis/173.3.627</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>FirstPage, Year, Author_FamilyName_2, Author_FamilyName_1, VolumeID, ArticleTitle</td><td>CrossRef</td></tr><tr><td>CR9</td><td>BibArticle</td><td>Williams NA, Hirst TR, Nashar TO. Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic.<Emphasis Type="Italic">Immunol Today</Emphasis>. 1999;20:95&#8211;101.</td><td><a href=http://dx.doi.org/10.1016/S0167-5699(98)01397-8>10.1016/S0167-5699(98)01397-8</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR10</td><td>BibArticle</td><td>van Ginkel FW, Jackson RJ, Yuki Y, McGhee JR. Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues.<Emphasis Type="Italic">J Immunol</Emphasis>. 2000;165:4778&#8211;4782.</td><td><a href=http://dx.doi.org/10.4049/jimmunol.165.9.4778>10.4049/jimmunol.165.9.4778</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_1, VolumeID, Author_FamilyName_2, ArticleTitle, Year, FirstPage</td><td>CrossRef</td></tr><tr><td>CR11</td><td>BibArticle</td><td>Krieg AM. Immune effects and mechanisms of action of CpG motifs.<Emphasis Type="Italic">Vaccine</Emphasis>. 2000;19:618&#8211;622.</td><td><a href=http://dx.doi.org/10.1016/S0264-410X(00)00249-8>10.1016/S0264-410X(00)00249-8</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR12</td><td>BibArticle</td><td>McCluskie MJ, Davis HL. CpG DNA as mucosal adjuvant.<Emphasis Type="Italic">Vaccine</Emphasis>. 1999;18:231&#8211;237.</td><td><a href=http://dx.doi.org/10.1016/S0264-410X(99)00194-2>10.1016/S0264-410X(99)00194-2</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR13</td><td>BibArticle</td><td>Babiuk S, Baca-Estrada ME, Middleton DM, Hecker R, Babiuk LA, Foldvari M. Biphasic lipid vesicles (Biphasix) enhance the adjuvanticity of CpG oligonucleotides following systemic and mucosal administration.<Emphasis Type="Italic">Curr Drug Deliv</Emphasis>. 2004;1:9&#8211;15.</td><td><a href=http://dx.doi.org/10.2174/1567201043479993>10.2174/1567201043479993</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR14</td><td>BibArticle</td><td>Alcon VL, Foldvari M, Snider M, et al. Induction of protective immunity in pigs after immunisation with CpG oligodeoxynucleotides formulated in a lipid-based delivery systems (Biphasix).<Emphasis Type="Italic">Vaccine</Emphasis>. 2003;21:1811&#8211;1814.</td><td><a href=http://dx.doi.org/10.1016/S0264-410X(03)00003-3>10.1016/S0264-410X(03)00003-3</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR15</td><td>BibArticle</td><td>Gerlach GF, Anderson C, Klashinsky S, Rossi-Campos A, Potter AA, Willson PJ. Molecular characterization of a protective outer membrane lipoprotein (OmlA) from Actinobacillus pleuropneumoniae serotype 1.<Emphasis Type="Italic">Infect Immun</Emphasis>. 1993;61:565&#8211;572.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR16</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Foldvari</span> <span style='background:#DDDDDD'>M</span></span>, <span style='background:#BDBAD6'>inventor. US patent 5 853 755. December 29,</span></aug> <span style='background:#66FF66'>1998</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR17</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Foldvari</span> <span style='background:#DDDDDD'>M</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Baca-Estrada</span> <span style='background:#DDDDDD'>ME</span></span>, <span style='background:#BDBAD6'>inventor. US patent 5 993 852. November 30,</span></aug> <span style='background:#66FF66'>1999</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR18</td><td>BibArticle</td><td>Rankin R, Pontarollo R, Ioannou X, et al. CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved.<Emphasis Type="Italic">Antisense Nucleic Acid Drug Dev.</Emphasis> 2001;11:333&#8211;340.</td><td><a href=http://dx.doi.org/10.1089/108729001753231713>10.1089/108729001753231713</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR19</td><td>BibArticle</td><td>Foss DL, Murtaugh MP. Mucosal immunogenicity and adjuvanticity of cholera toxin in swine.<Emphasis Type="Italic">Vaccine</Emphasis>. 1999;17: 788&#8211;801.</td><td><a href=http://dx.doi.org/10.1016/S0264-410X(98)00263-1>10.1016/S0264-410X(98)00263-1</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR20</td><td>BibArticle</td><td>Capozzo AV, Cuberos L, Levine MM, Pasetti MF. Mucosally delivered Salmonella live vector vaccines elicit potent immune responses against a foreign antigen in neonatal mice born to naive and immune mothers.<Emphasis Type="Italic">Infect Immun.</Emphasis> 2004;72:4637&#8211;4646.</td><td><a href=http://dx.doi.org/10.1128/IAI.72.8.4637-4646.2004>10.1128/IAI.72.8.4637-4646.2004</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR21</td><td>BibArticle</td><td>Gockel CM, Bao S, Beagley KW. Transcutaneous immunization induces mucosal and systemic immunity: a potent method for targeting immunity to the female reproductive tract.<Emphasis Type="Italic">Mol Immunol</Emphasis>. 2000;37:537&#8211;544.</td><td><a href=http://dx.doi.org/10.1016/S0161-5890(00)00074-2>10.1016/S0161-5890(00)00074-2</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR22</td><td>BibArticle</td><td>Snider DP. The mucosal adjuvant activities of ADP-ribosylating bacterial enterotoxins.<Emphasis Type="Italic">Crit Rev Immunol</Emphasis>. 1995;15:317&#8211;348.</td><td><a href=http://dx.doi.org/10.1615/CritRevImmunol.v15.i3-4.70>10.1615/CritRevImmunol.v15.i3-4.70</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>VolumeID, Author_FamilyName_1, ArticleTitle, Year, FirstPage</td><td>CrossRef</td></tr><tr><td>CR23</td><td>BibArticle</td><td>Glenn GM, Scharton-Kersten T, Vassell R, Mallett CP, Hale TL, Alving CR. Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge.<Emphasis Type="Italic">J Immunol</Emphasis>. 1998;161:3211&#8211;3214.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR24</td><td>BibArticle</td><td>Gallichan WS, Woolstencroft RN, Guarasci T, McCluskie MJ, Davis HL, Rosenthal KL. Intranasal immunization with CpG oligodeoxynucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract.<Emphasis Type="Italic">J Immunol</Emphasis>. 2001;166:3451&#8211;3457.</td><td><a href=http://dx.doi.org/10.4049/jimmunol.166.5.3451>10.4049/jimmunol.166.5.3451</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Year, FirstPage, Author_FamilyName_1, VolumeID, Author_FamilyName_2, ArticleTitle</td><td>CrossRef</td></tr><tr><td>CR25</td><td>BibArticle</td><td>McCluskie MJ, Weeratna RD, Davis HL. Intranasal immunization of mice with CpG DNA induces strong systemic and mucosal responses that are influenced by other mucosal adjuvants and antigen distribution.<Emphasis Type="Italic">Mol Med</Emphasis>. 2000;6:867&#8211;877.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR26</td><td>BibArticle</td><td>McCluskie MJ, Weeratna RD, Davis HL. The potential of oligodeoxynucleotides as mucosal and parenteral adjuvants.<Emphasis Type="Italic">Vaccine</Emphasis>. 2001;19:2657&#8211;2660.</td><td><a href=http://dx.doi.org/10.1016/S0264-410X(00)00496-5>10.1016/S0264-410X(00)00496-5</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR27</td><td>BibArticle</td><td>Olszewska W, Partidos CD, Steward MW. Antipeptide antibody responses following intranasal immunization: effectiveness of mucosal adjuvants.<Emphasis Type="Italic">Infect Immun</Emphasis>. 2000;68:4923&#8211;4929.</td><td><a href=http://dx.doi.org/10.1128/IAI.68.9.4923-4929.2000>10.1128/IAI.68.9.4923-4929.2000</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR28</td><td>BibArticle</td><td>Babiuk S, Baca-Estrada ME, Pontarollo R, Foldvari M. Topical delivery of plasmid DNA using biphasic lipid vesicles (Biphasix).<Emphasis Type="Italic">J Pharm Pharmacol</Emphasis>. 2002;54:1609&#8211;1614.</td><td><a href=http://dx.doi.org/10.1211/002235702289>10.1211/002235702289</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR29</td><td>BibArticle</td><td>Farman CA, Kornbrust DJ. Oligodeoxynucleotide studies in primates: antisense and immune stimulatory indications.<Emphasis Type="Italic">Toxicol Pathol</Emphasis>. 2003;31:119&#8211;122.</td><td><a href=http://dx.doi.org/10.1080/01926230309779>10.1080/01926230309779</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>ArticleTitle, VolumeID, Author_FamilyName_1, Author_FamilyName_2, Year, FirstPage</td><td>CrossRef</td></tr><tr><td>CR30</td><td>BibArticle</td><td>Klimuk SK, Semple SC, Nahimey PN, et al. Enhanced anti-inflammatory activity of a liposomal intercellular adhesion molecule-1 antisense oligodeoxynucleotide in an acute model of contact hypersensitivity.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2000;292:480&#8211;488.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR31</td><td>BibArticle</td><td>De Oliveira MC, Boutet V, Fattal E, et al. Improvement of in vivo stability of phosphodiester oligonucleotide using anionic liposomes in mice.<Emphasis Type="Italic">Life Sci</Emphasis>. 2000;67:1625&#8211;1637.</td><td><a href=http://dx.doi.org/10.1016/S0024-3205(00)00745-1>10.1016/S0024-3205(00)00745-1</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR32</td><td>BibArticle</td><td>Murphy BR, Nelson DL, Wright PF, Tierney EL, Phelan MA, Chanock RM. Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines.<Emphasis Type="Italic">Infect Immun</Emphasis>. 1982;36:1102&#8211;1108.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr></table>